SCHEMBL24110492

SCHEMBL24110492

CC(C(=O)n1ccc2ccc(F)cc21)N(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.43
HTR2A P28223 4/20 0.43
FABP4 P15090 1/20 0.38
HTR7 P34969 2/20 0.35
NPY5R Q15761 1/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
HTR1F P30939 1/20 0.34
NOTUM Q6P988 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TP53 P04637 1/20 0.34
NR3C2 P08235 1/20 0.34
KCNH2 Q12809 1/20 0.33
TFPI2 P48307 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110382 1.00 HTR2C (0.43) HTR2CHTR2AFABP4HTR7NPY5R
SCHEMBL24110376 1.00 HTR2C (0.43) HTR2CHTR2AFABP4HTR7NPY5R
SCHEMBL24110329 0.89 HTR2A (0.43) HTR2CHTR2AFABP4HTR7NPY5R
SCHEMBL24110490 0.89 HTR2A (0.43) HTR2CHTR2AFABP4HTR7NPY5R
SCHEMBL24109788 0.89 HTR2A (0.43) HTR2CHTR2AFABP4HTR7NPY5R
SCHEMBL24110379 0.84 HTR2A (0.42) HTR2CHTR2ANPY5RNOTUM
SCHEMBL24110387 0.84 HTR2A (0.42) HTR2CHTR2ANPY5RNOTUM
SCHEMBL24110349 0.84 HTR2A (0.42) HTR2CHTR2ANPY5RNOTUM
SCHEMBL24109792 0.81 TFPI2 (0.47) HTR2CHTR2AFABP4TFPI2
SCHEMBL24109905 0.81 TFPI2 (0.47) HTR2CHTR2AFABP4TFPI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT HTR2C 35/4885HTR2A 10/4885FABP4 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.